Cryoablation and Post-Progression Immune Checkpoint Inhibition in Metastatic Melanoma: A Phase II Trial

In this non-randomized phase II single-center study, subjects with unresectable melanoma progressing on immune checkpoint inhibition (ICI) underwent cryoablation of an enlarging metastasis, and ICI was continued for a minimum of two additional cycles.